NCT07598838Active, not recruiting
Fitness in Elderly AML Patients
Multicenter Retrospective Observational Study to Verify the Application of SIE/SIES/GITMO FITNESS CRITERIA to Guide Therapeutic Choice in Elderly Patients With Acute Myeloid Leukemia in Light of the Availability of New Drugs - AML FITNESS
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
The study aims to evaluate the outcome of patients (overall survival) who received treatments commensurate with the proposed "Fitness" parameters compared to that of patients whose treatment differed either in the direction of greater or lesser aggressiveness than that proposed (evaluation of survival through Kaplan-Meier analysis and comparison with the log-rank test).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 725 (actual)
- First submitted
- 14 May 2026
- Start date
- 1 Jan 2020
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT07598838
What you commit to
- Study type: Observational
- Participants enrolled: 725
- From 1 Jan 2020 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Acute Myeloid Leukemia Diagnosis no Acute Promyelocytic Leukemia aged more than 65 years
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ASST Spedali Civili di Brescia Coordinator of this site? Confirm its status | Brescia | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.